{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:29:56Z","timestamp":1791815396935,"version":"4.3.4"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010002","name":"Executive Yuan Republic of China Ministry of Education","doi-asserted-by":"publisher","award":["NTU-114L900701"],"award-info":[{"award-number":["NTU-114L900701"]}],"id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 114-2221-E-A49-144-MY3"],"award-info":[{"award-number":["NSTC 114-2221-E-A49-144-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113-2221-E-002-149-MY3"],"award-info":[{"award-number":["NSTC 113-2221-E-002-149-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NTU-CC-114L892702"],"award-info":[{"award-number":["NTU-CC-114L892702"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NTU-114L8514"],"award-info":[{"award-number":["NTU-114L8514"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.drudis.2026.104620","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T01:07:53Z","timestamp":1770253673000},"page":"104620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Reactive oxygen species driven immune inflammation in systemic sclerosis: mechanisms and emerging therapeutics"],"prefix":"10.1016","volume":"31","author":[{"given":"Shih-Ching","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuang-Hui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsuan-Cheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4876-3309","authenticated-orcid":false,"given":"Hsueh-Fen","family":"Juan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2026.104620_b0005","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41584-024-01217-2","article-title":"An international perspective on the future of systemic sclerosis research","volume":"21","author":"Abraham","year":"2025","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.drudis.2026.104620_b0010","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/rheumatology\/kez486","article-title":"Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study","volume":"59","author":"Jaeger","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.drudis.2026.104620_b0015","article-title":"Systemic sclerosis: state of the art on clinical practice guidelines","volume":"4","author":"Smith","year":"2018","journal-title":"RMD Open"},{"key":"10.1016\/j.drudis.2026.104620_b0020","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.3389\/fphys.2018.01177","article-title":"The role of oxidative stress in the development of systemic sclerosis related vasculopathy","volume":"9","author":"Abdulle","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.drudis.2026.104620_b0025","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1089\/ars.2017.7083","article-title":"The reactive species interactome: Evolutionary emergence, biological significance, and opportunities for redox metabolomics and personalized medicine","volume":"27","author":"Cortese-Krott","year":"2017","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.drudis.2026.104620_b0030","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.3390\/antiox12051006","article-title":"Oxidative stress and antioxidant therapy in pulmonary hypertension","volume":"12","author":"Poyatos","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.drudis.2026.104620_b0035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/sclerosis3020017","article-title":"Pathophysiology in systemic sclerosis: current insights and future perspectives","volume":"3","author":"Al-Gburi","year":"2025","journal-title":"Sclerosis"},{"key":"10.1016\/j.drudis.2026.104620_b0040","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s10495-021-01663-3","article-title":"Release mechanisms of major DAMPs","volume":"26","author":"Murao","year":"2021","journal-title":"Apoptosis"},{"key":"10.1016\/j.drudis.2026.104620_b0045","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/antiox6030054","article-title":"Reactive oxygen and nitrogen species in the development of pulmonary hypertension","volume":"6","author":"Fulton","year":"2017","journal-title":"Antioxidants"},{"key":"10.1016\/j.drudis.2026.104620_b0050","first-page":"4431","article-title":"Nox4-derived ROS signaling contributes to TGF-\u03b2-induced epithelial-mesenchymal transition in pancreatic cancer cells","volume":"33","author":"Hiraga","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1016\/j.drudis.2026.104620_b0055","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/s12276-023-00965-7","article-title":"Molecular mechanisms of mitochondrial DNA release and activation of the cGAS-STING pathway","volume":"55","author":"Kim","year":"2023","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.drudis.2026.104620_b0060","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/art.41153","article-title":"Using autoantibodies and cutaneous subset to develop outcome-based disease classification in systemic sclerosis","volume":"72","author":"Nihtyanova","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.drudis.2026.104620_b0065","article-title":"Emerging role of hypoxia-inducible factor-1\u03b1 in inflammatory autoimmune diseases: a comprehensive review","volume":"13","author":"Tang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2026.104620_b0070","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12964-018-0268-4","article-title":"Activation of the JAK\/STAT3 and PI3K\/AKT pathways are crucial for IL-6 trans-signaling-mediated pro-inflammatory response in human vascular endothelial cells","volume":"16","author":"Zegeye","year":"2018","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.drudis.2026.104620_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101122","article-title":"Implication of oxidative stress in the pathogenesis of systemic sclerosis via inflammation, autoimmunity and fibrosis","volume":"25","author":"Doridot","year":"2019","journal-title":"Redox Biol"},{"key":"10.1016\/j.drudis.2026.104620_b0080","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1186\/ar596","article-title":"Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers","volume":"4","author":"Distler","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1016\/j.drudis.2026.104620_b0085","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1186\/s12967-024-05403-4","article-title":"Macrophages as determinants and regulators of systemic sclerosis-related interstitial lung disease","volume":"22","author":"Lee","year":"2024","journal-title":"J Transl Med"},{"key":"10.1016\/j.drudis.2026.104620_b0090","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1146\/annurev.physiol.63.1.427","article-title":"Somatic gene therapy in the cardiovascular system","volume":"63","author":"Baumgartner","year":"2001","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.drudis.2026.104620_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2019.103881","article-title":"Imbalanced serum levels of Ang1, Ang2 and VEGF in systemic sclerosis: Integrated effects on microvascular reactivity","volume":"125","author":"Michalska-Jakubus","year":"2019","journal-title":"Microvasc Res"},{"key":"10.1016\/j.drudis.2026.104620_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111329","article-title":"Class-3 semaphorins: Potent multifunctional modulators for angiogenesis-associated diseases","volume":"137","author":"Jiao","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.drudis.2026.104620_b0105","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s13075-015-0749-4","article-title":"Plexin-D1\/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis","volume":"17","author":"Mazzotta","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.drudis.2026.104620_b0110","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.3390\/ijms23073904","article-title":"PDGF\/PDGFR: a possible molecular target in scleroderma fibrosis","volume":"23","author":"Paolini","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2026.104620_b0115","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/art.24365","article-title":"Lack of detection of agonist activity by antibodies to platelet-derived growth factor receptor alpha in a subset of normal and systemic sclerosis patient sera","volume":"60","author":"Loizos","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.drudis.2026.104620_b0120","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1161\/CIRCULATIONAHA.112.094722","article-title":"Aldosterone inactivates the endothelin-B receptor via a cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterial hypertension","volume":"126","author":"Maron","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.drudis.2026.104620_b0125","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.3390\/biomedicines10112765","article-title":"Profibrotic effects of endothelin-1 on fibroblasts are mediated by aldosterone in vitro: Relevance to the pathogenesis and therapy of systemic sclerosis and pulmonary arterial hypertension","volume":"10","author":"Argentino","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.drudis.2026.104620_b0130","doi-asserted-by":"crossref","first-page":"23098","DOI":"10.1074\/jbc.M311430200","article-title":"Endothelin-1 induces expression of matrix-associated genes in lung fibroblasts through MEK\/ERK","volume":"279","author":"Xu","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2026.104620_b0135","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/annrheumdis-2016-210229","article-title":"Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis","volume":"76","author":"Manetti","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.drudis.2026.104620_b0140","first-page":"62","article-title":"The role of endothelin-1 in pulmonary arterial hypertension","volume":"2014","author":"Chester","year":"2014","journal-title":"Glob Cardiol Sci Pract"},{"key":"10.1016\/j.drudis.2026.104620_b0145","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11926-009-0015-3","article-title":"Is scleroderma a vasculopathy?","volume":"11","author":"Fleming","year":"2009","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.drudis.2026.104620_b0150","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12929-018-0423-7","article-title":"Molecular mechanisms underlying therapeutic potential of pericytes","volume":"25","author":"Harrell","year":"2018","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.drudis.2026.104620_b0155","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ceb.2004.07.010","article-title":"Regulation of matrix biology by matrix metalloproteinases","volume":"16","author":"Mott","year":"2004","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.drudis.2026.104620_b0160","doi-asserted-by":"crossref","first-page":"H647","DOI":"10.1152\/ajpheart.00090.2018","article-title":"Role of matrix metalloproteinases and histone deacetylase in oxidative stress-induced degradation of the endothelial glycocalyx","volume":"316","author":"Ali","year":"2019","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.drudis.2026.104620_b0165","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/BOR.0000000000000963","article-title":"The contribution of endothelial cells to tissue fibrosis","volume":"36","author":"Romano","year":"2024","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.drudis.2026.104620_b0170","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1523-1747.1999.00476.x","article-title":"Monocytes of patients wiht systemic sclerosis (scleroderma spontaneously release in vitro increased amounts of superoxide anion","volume":"112","author":"Sambo","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.drudis.2026.104620_b0175","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s42003-023-04748-8","article-title":"Lysyl oxidase-like 2 processing by factor Xa modulates its activity and substrate preference","volume":"6","author":"Wang","year":"2023","journal-title":"Commun Biol"},{"key":"10.1016\/j.drudis.2026.104620_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2023.101645","article-title":"Association between the degree of severity of pulmonary hypertension with the presence of pulmonary artery aneurysm: a brief updated review for clinicians","volume":"48","author":"Torres-Rojas","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.drudis.2026.104620_b0185","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1161\/01.CIR.94.7.1578","article-title":"Human pulmonary circulation is an important site for both clearance and production of endothelin-1","volume":"94","author":"Dupuis","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.drudis.2026.104620_b0190","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s12016-022-08945-x","article-title":"Renal disease and systemic sclerosis: an update on scleroderma renal crisis","volume":"64","author":"Cole","year":"2023","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.drudis.2026.104620_b0195","doi-asserted-by":"crossref","first-page":"iii32","DOI":"10.1093\/rheumatology\/ken483","article-title":"Renal complications and scleroderma renal crisis","volume":"48","author":"Denton","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.drudis.2026.104620_b0200","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/art.40809","article-title":"Generation of a core set of items to develop classification criteria for scleroderma renal crisis using consensus methodology","volume":"71","author":"Butler","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.drudis.2026.104620_b0205","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41584-023-00909-5","article-title":"State-of-the-art evidence in the treatment of systemic sclerosis","volume":"19","author":"Pope","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.drudis.2026.104620_b0210","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.3390\/jcm13144127","article-title":"Anti-inflammatory and anti-oxidant properties of N-acetylcysteine: a fresh perspective","volume":"13","author":"Santus","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.drudis.2026.104620_b0215","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.bbi.2017.02.018","article-title":"Oral administration of the nitroxide radical TEMPOL exhibits immunomodulatory and therapeutic properties in multiple sclerosis models","volume":"62","author":"Neil","year":"2017","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.drudis.2026.104620_b0220","article-title":"MitoQ protects against oxidative stress-induced mitochondrial dysregulation in human cardiomyocytes","volume":"13","author":"Parker","year":"2025","journal-title":"J Mol Cell Cardiol Plus"},{"key":"10.1016\/j.drudis.2026.104620_b0225","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10753-018-0907-3","article-title":"Statins inhibit cytokines in a dose-dependent response in patients with systemic sclerosis","volume":"42","author":"Goncalves","year":"2019","journal-title":"Inflammation"},{"key":"10.1016\/j.drudis.2026.104620_b0230","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1007\/s10067-025-07557-y","article-title":"Stem cell therapy in systemic sclerosis","volume":"44","author":"Sakkas","year":"2025","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.drudis.2026.104620_b0235","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.1016\/S2665-9913(21)00107-7","article-title":"Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial","volume":"3","author":"Ebata","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.drudis.2026.104620_b0240","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/S2665-9913(24)00282-0","article-title":"CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series","volume":"7","author":"Auth","year":"2025","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.drudis.2026.104620_b0245","doi-asserted-by":"crossref","first-page":"e743","DOI":"10.1016\/S2665-9913(20)30237-X","article-title":"Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial","volume":"2","author":"Chung","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.drudis.2026.104620_b0250","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/s41467-017-01236-6","article-title":"Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis","volume":"8","author":"Chakraborty","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104620_b0255","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S2213-2600(20)30554-3","article-title":"Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial","volume":"9","author":"Behr","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.drudis.2026.104620_b0260","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/14397595.2019.1696505","article-title":"Nintedanib: New indication for systemic sclerosis-associated interstitial lung disease","volume":"30","author":"Kuwana","year":"2020","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.drudis.2026.104620_b0265","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","article-title":"Nintedanib for systemic sclerosis-associated interstitial lung disease","volume":"380","author":"Distler","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.drudis.2026.104620_b0270","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S2213-2600(20)30318-0","article-title":"Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"8","author":"Khanna","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.drudis.2026.104620_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2024.104914","article-title":"The effect of tocilizumab treatment for skin fibrosis by inhibiting CD38+ macrophages in systemic sclerosis","volume":"408","author":"Chen","year":"2025","journal-title":"Cell Immunol"},{"key":"10.1016\/j.drudis.2026.104620_b0280","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1136\/annrheumdis-2020-218447","article-title":"A randomised, double-blind, placebo-controlled, 24-week, phase II, proof-of-concept study of romilkimab (SAR156597) in early diffuse cutaneous systemic sclerosis","volume":"79","author":"Allanore","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.drudis.2026.104620_b0285","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/art.42510","article-title":"Efficacy and safety of lenabasum, a cannabinoid type 2 receptor agonist, in a Phase 3 randomized trial in diffuse cutaneous systemic sclerosis","volume":"75","author":"Spiera","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.drudis.2026.104620_b0290","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1080\/13543784.2021.1923693","article-title":"New promising drugs for the treatment of systemic sclerosis: pathogenic considerations, enhanced classifications, and personalized medicine","volume":"30","author":"Lescoat","year":"2021","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.drudis.2026.104620_b0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2025.106078","article-title":"Selective JAK-1 inhibitor Upadacitinib and peptide PD29 modulate the JAK and TGF-beta\/Smad signaling pathways reducing experimental dermal fibrosis","volume":"107","author":"Kocak","year":"2025","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.drudis.2026.104620_b0300","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1007\/s10067-025-07433-9","article-title":"BAricitinib in patients with SystemIC Sclerosis (BASICS): a prospective, open-label, randomised trial","volume":"44","author":"Chen","year":"2025","journal-title":"Clin Rheumatol"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644626000255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644626000255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:44:35Z","timestamp":1778802275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644626000255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1359644626000255"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104620","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reactive oxygen species driven immune inflammation in systemic sclerosis: mechanisms and emerging therapeutics","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104620","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104620"}}